Evidence map›Paper›PMID 27941788›Full record

ArticleNature neuroscience2017

Small-molecule inhibition of STOML3 oligomerization reverses pathological mechanical hypersensitivity.

Christiane Wetzel, Simone Pifferi, Cristina Picci, Caglar Gök, Diana Hoffmann, Kiran K Bali, André Lampe, Liudmila Lapatsina, Raluca Fleischer, Ewan St John Smith and 14 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Piezo1 selectively enhances TGF-β1-induced IgA class switching by B cells.Cellular and molecular life sciences : CMLS · 2025
    Article
  13. Article
  14. In the activation of HPV-specific human B cells HPV-VLP vaccines mimic membrane-associated antigens.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Review
  16. Pharmacology of PIEZO1 channels.British journal of pharmacology · 2024
    Review
  17. Piezo ion channels: long-sought-after mechanosensors mediating hypertension and hypertensive nephropathy.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 5 institutions in 6 countries.

Christiane WetzelDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Simone PifferiDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Cristina PicciDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Caglar GökDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Diana HoffmannDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Kiran K BaliInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-9503-1402
André LampeLeibniz-Institut für Molekulare Pharmakologie (FMP), Berlin, Germany.
Liudmila LapatsinaDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Raluca FleischerDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Ewan St John SmithDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.ORCID 0000-0002-2699-1979
Valérie BégayDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Mirko MoroniDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Luc EstebanezDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Johannes KühnemundDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Jan WalcherDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Edgar SpeckerLeibniz-Institut für Molekulare Pharmakologie (FMP), Berlin, Germany.
Martin NeuenschwanderLeibniz-Institut für Molekulare Pharmakologie (FMP), Berlin, Germany.
Jens Peter von KriesLeibniz-Institut für Molekulare Pharmakologie (FMP), Berlin, Germany.
Volker HauckeLeibniz-Institut für Molekulare Pharmakologie (FMP), Berlin, Germany.
Rohini KunerInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
James F A PouletDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Jan SchmoranzerFreie Universität Berlin, Berlin, Germany.
Kate PooleDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Gary R LewinDepartment of Neuroscience, Max Delbrück Center for Molecular Medicine, Berlin, Germany.ORCID 0000-0002-2890-6352
Max Delbrück Center · DELeibniz-Forschungsinstitut für Molekulare Pharmakologie · DEHeidelberg University · DEFreie Universität Berlin · DEUniversity of Cagliari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The skin is equipped with specialized mechanoreceptors that allow the perception of the slightest brush. Indeed, some mechanoreceptors can detect even nanometer-scale movements. Movement is transformed into electrical signals via the gating of mechanically activated ion channels at sensory endings in the skin. The sensitivity of Piezo mechanically gated ion channels is controlled by stomatin-like protein-3 (STOML3), which is required for normal mechanoreceptor function. Here we identify small-molecule inhibitors of STOML3 oligomerization that reversibly reduce the sensitivity of mechanically gated currents in sensory neurons and silence mechanoreceptors in vivo. STOML3 inhibitors in the skin also reversibly attenuate fine touch perception in normal mice. Under pathophysiological conditions following nerve injury or diabetic neuropathy, the slightest touch can produce pain, and here STOML3 inhibitors can reverse mechanical hypersensitivity. Thus, small molecules applied locally to the skin can be used to modulate touch and may represent peripherally available drugs to treat tactile-driven pain following neuropathy.

Indexed as

AnimalsGanglia, SpinalHypersensitivityIon ChannelsMechanoreceptorsMechanotransduction, CellularMembrane ProteinsMice, Inbred C57BLMice, TransgenicNerve Tissue ProteinsSensory Receptor CellsSkinTouchIon ChannelsMembrane ProteinsNerve Tissue ProteinsStoml3 protein, mouse

Identifiers

PMID27941788
OpenAlexW2566243317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.